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Abstract
Background: Infertility is a critical condition in women with polycystic ovary syndrome
(PCOS), caused not only by anovulation but also by endometrial abnormality.
Objective: This study aimed to evaluate and compare the hysteroscopic and
histological findings of endometrial biopsies in infertile women with PCOS and normal
endometrial thickness and women with unexplained infertility (UI).
Materials and Methods: This cross-sectional study compared the initial hysteroscopy
and endometrial histological findings of 70 infertile women with PCOS and normal
endometrial thickness with those of 35 women with UI. The relationship between
endometrial histology and clinical parameters such as including luteinizing hormone,
follicle-stimulating hormone, thyroid-stimulating hormone, testosterone, prolactin,
fasting blood sugar, body mass index (BMI), and infertility duration was analyzed.
Results: The mean age of women with PCOS was significantly lower than that of
women with UI (27.5 ± 4.1 vs. 30 ± 4.5 years, respectively) (p < 0.001). The mean
BMI was higher in women with PCOS than in women with UI (28.7 ± 4.4 vs. 25.1 ±
3 kg/m2) (p < 0.001). The hysteroscopic findings of all women with PCOS were normal,
whereas 91.4% of women with UI had normal hysteroscopic findings, 2.9% had a polyp,
and 5.7% had endometrial thickening. The histological findings of women with PCOS
revealed proliferative endometrium in 54.3%, disordered proliferative endometrium in
17.1%, secretory endometrium in 8.6%, and endometrial polyp in 17.1%, whereas these
percentages in women with UI were 28.6%, 0%, 54.3%, and 20%, respectively.
Conclusion: The hysteroscopic evaluation alone of infertile women might not detect all
probable endometrial pathologies in women with PCOS.
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1. Introduction
Polycystic ovary syndrome (PCOS) is a highly
prevalent endocrine-metabolic disorder in women
of reproductive ages, and its estimated global
prevalence is 5%-10% (1-3). It is characterized by
irregular menstruation/oligomenorrhea, hirsutism,
acne, oligo/anovulation, hyperandrogenemia,
polycystic ovaries, and infertility (3). According
to Rotterdam International Consensus Group, at
least two of the following three criteria should be
present to diagnose PCOS: oligo/anovulation,
elevated levels of circulating androgens or
clinical manifestation of androgen excess,
and polycystic ovaries on ultrasonography
(3, 4). Infertility is a vital concern in women
with PCOS, and about 80% of infertile women
with anovulatory cycles present with conditions
listed in the above diagnostic criteria for PCOS
(5). Improvements in ovarian function and
ovulation are major challenges for clinicians
and researchers in the management of such
women, wherein treatment mainly includes
medications such as clomiphene citrate, raloxifene,
tamoxifen, metformin, aromatase inhibitors, and
glucocorticoids as well as surgical management
by laparoscopic ovarian drilling (3). Several
studies have assessed the etiology of anovulation
resulting in infertility in these women; however,
studies on the endometrium of women with
PCOS are limited (3). Women with improved
ovulation through medical therapy reportedly
have a higher incidence of implantation failure
and spontaneous abortion (3) possibly because
of reduced levels of progesterone levels and
elevated levels of free insulin levels, insulin
growth factor-1, androgens, and luteinizing
hormone (LH) during menstrual cycles (3, 6).
There is evidence, therefore, suggesting that
both anovulation and endometrial abnormality
cause infertility in such women (2, 3, 6-
8).
Prolonged unopposed estrogen,
hyperinsulinemia, and elevated levels of free
insulin, growth factor-1, and androgens increase the
proliferative activity of the endometrium, resulting
in hyperplasia and carcinoma acceleration (3).
However, whether women with PCOS without
endometrial thickness on ultrasonography require
an endometrial biopsy to assess endometrial
disorders remains controversial (9).
Therefore, this study aimed to evaluate the
endometrium using hysteroscopy and endometrial
histology in women with no endometrial thickness
on transvaginal ultrasonography and assess
its relationship with infertility duration and
hormonal patterns in infertile women with PCOS
in comparison with women with unexplained
infertility (UI).
2. Materials and Methods
2.1. Study design
This retrospective cross-sectional study was
performed from January 2012 to January 2015. The
data obtained from the medical records of patients
at the Gynecology Department of Hazrat Zainab
Hospital affiliated to Shiraz University of Medical
Sciences were retrospectively reviewed and 105
patients were selected.
2.2. Patients
Female patients aged 15-38 yr with a positive
history of infertility without any response to
ovulation induction therapy and normal semen
analyses of their husbands were included in the
study. Diagnostic laparoscopy, hysteroscopy,
laparoscopic ovarian cautery, and endometrial
biopsies were performed in these women.
Patients were divided into the following two
groups. The PCO group comprised 70 infertile
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women diagnosed with PCOS, in accordance
with the Rotterdam criteria (4), and with normal
endometrial thickness on vaginal ultrasonography,
normal hysterosalpingographic findings, and
no pelvic pathologies such as adhesion and
endometriosis on diagnostic laparoscopy.
The UI group comprised 35 patients with UI
and normal endometrial thickness on vaginal
ultrasonography and normal laparoscopic
findings. Those who used progesterone
supplementation 3-6 months prior to hysteroscopy
were excluded.
For both the groups, the exclusion criteria
were underlying diseases such as hypertension,
diabetes mellitus, cardiovascular diseases,
thyroid disorders (patients with abnormal
thyroid function tests), hyperprolactinemia,
and endometrial lesions, such as leiomyoma
and endometrial polyp, on ultrasonography, and
positive family history of endometrial cancer.
2.3. Data collection
Demographic data collected from the medical
records included age, weight, BMI (weight [kg]
divided by height in meters squared [m2]),
obstetrics and gynecology history (duration of
infertility and variability of menstrual cycles), and
medications. Obesity was defined as BMI of >30
kg/m2 and overweight as BMI of >25 kg/m2.
Physical and laboratory examinations (e.g.,
follicle-stimulating hormone [FSH], LH, thyroid-
stimulating hormone [TSH], testosterone,
prolactin, fasting blood sugar [FBS], and
semen analyses of their husbands) were also
performed. Impaired fasting blood sugar was
defined as FBS of >100 mg/dL. The FSH and
LH levels of the patients were measured on
days 3 and 4 of the menstrual cycle. FSH, LH,
testosterone, prolactin, and TSH levels were
measured using AccuBind® ELISA, Monobind
Inc, USA. The normal ranges are as follows:
TSH, 0.39-6.16 𝜇IU/mL; FSH, 3.0-12.0 mIU/mL in
the follicular phase; LH, 5.0-10.5 mIU/mL in the
follicular phase; testosterone, 0.2-0.95ng/mL;
and prolactin, 1.2-19.5 ng/mL.
Vaginal ultrasonography (used to report
endometrial thickness), hysterosalpingography,
laparoscopy, and correlative endometrial biopsy
reports were obtained from the patients’ medical
records.
2.4. Ethical consideration
The study protocol was approved by the
Research Ethics Committee of Shiraz University
of Medical Sciences (Approval Number:
IR.SUMS.REC.1394.S1171). Written informed
consent was obtained from the patients.
2.5. Statistical analysis
The SPSS software for Windows version 17
(SPSS Inc. Released 2008, Chicago) was used to
analyze statistical data. Descriptive information
is presented as mean and standard deviation
(SD). In both the groups, hormonal assessment
results, including serum levels of TSH, LH, FSH,
testosterone, and prolactin, were categorized
as high, low, or medium, and Fisher’s exact
test, chi-square, and Kruskal-Wallis tests were
used to analyze qualitative data. The normality
of data was analyzed using the Kruskal-Wallis
test, and because the clinical parameters did not
show a normal distribution, the Mann-Whitney U
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test was used to compare the quantitative data
between the two groups. The contingency and
eta coefficients were used to understand the
correlations between data. P values of <0.05
were considered statistically significant.
3. Results
Comparisons of the PCOS and UI groups
revealed that the mean age was significantly
lower and BMI was significantly higher in the
PCOS group than in the UI group (both p <
0.001) (Table I). The prevalence of obesity
and overweight was 37.15% and 47.15% in
the PCOS group and 5.7% and 51.45% in the
UI group, respectively. The FBS levels were
significantly higher in the PCOS group than
in UI group (99.20 ± 9.40 vs. 92.90 ± 9.50
mg/mL; p < 0.001). FBS of <100 mg/mL was
reported in 49.3% and 74.3% of patients in the
PCOS and UI groups, respectively. Patients
in the UI group patients had normal TSH, LH,
FSH, and testosterone levels, whereas those
in the PCOS group had different levels of
these hormones, and there were significant
differences in LH and testosterone levels
between the groups (p < 0.001) (Table II).
The results of the Mann-Whitney test showed
the LH/FSH ratio was higher in the PCOS
group than in the UI group (2.2 ± 1.6 vs. 1.1
± 0.6, respectively, p < 0.001). Hysteroscopic
findings revealed no abnormalities in the PCOS
group, where 91.4% of patients in the UI group
had normal findings, 5.7% had endometrial
thickening, and 2.9% had polyps (p < 0.001).
Laparoscopy revealed polycystic ovaries in all
the patients in the PCOS group and normal
findings in patients of the UI group. There
was a significant difference in histological
findings between the PCOS and UI groups (p
< 0.001) (Table III). The contingency coefficient
test, which evaluates the nominal and ordinal
variables, revealed no association between
hysteroscopic and histological findings (p
= 0.28, contingency coefficient = 0.3) and
between histological findings and serum
FSH, LH, and testosterone levels (p = 0.99,
0.6, and 0.3, respectively). Moreover, the eta
coefficient test for the nominal and ordinal
variables showed that the histological findings
were not associated with age, BMI, and
infertility duration (p = 0.2, 0.8, 0.7, and 0.2,
respectively).
Table I. The demographic characteristics of patients in the PCO and UI groups
PCO group UI group p value
Age (yr)* 27.50 ± 4.50 30.00 ± 4.10 <0.001
Body mass index (kg/m2)* 28.70 ± 4.40 25.10 ± 3.00 <0.001
Duration of infertility (yr)* 5.20 ± 3.10 3.90 ± 1.90 0.06
Endometrial thickness (mm)* 6.5 ± 1.8 6.6 ± 1.7 0.7
Metformin consumption* 51.5% 5.7% <0.001
Oligomenorrhea * 14.4% 0
Oligomenorrhea and hirsutism* 71.7% 0
Oligomenorrhea and hirsutism and
hirsutism *
7.1% 0
* Data presented as mean ± SD ** Data presented as percentage Chi-square test
Page 36 https://doi.org/10.18502/ijrm.v18i1.6195
International Journal of Reproductive BioMedicine Endometrial biopsy in infertile women with PCO
Table II. Comparison of the hormonal levels between the PCO and UI groups


























Data presented as percentage. Chi-square test
Table III. Comparison of histological findings between the PCO and UI groups
Histological findings UI group PCO group p value
Proliferative endometrium 10 (28.6) 38 (54.3)
Disordered proliferative endometrium 0 (0) 12 (17.1)
Secretory endometrium 19 (54.3) 6 (8.6)
Endometrial polyp 6 (17.1) 14 (20)
<0.001
Data presented as n (%). Chi-square test
4. Discussion
This study investigated the endometrial
abnormality of women with PCOS versus
women with UI. The inclusion criteria of
both the groups were normal endometrial
thickness on vaginal ultrasonography. The
results showed that all the women with PCOS
had normal hysteroscopic findings but different
histological findings. These results indicate that
direct visualization by hysteroscopy, known
as the gold standard tool for the diagnosis
and treatment of infertility and intrauterine
cavity abnormalities, may not be sufficient to
diagnose endometrial abnormalities in women
with PCOS.
Infertility is a major health concern, and
PCOS is considered as its common cause (10).
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Studies investigating the causes of infertility
in women with PCOS have mainly focused on
anovulation and ovarian dysfunction (3, 11).
Endometrial normality is an essential factor in
fertility (12); therefore, evaluating the endometrial
histology is an important step for identifying
endometrial disorders in women with PCOS (2).
While hysteroscopy can accurately diagnose
endometrial disorders such as endometrial polyps
and enable endometrial biopsy (13, 14) with
minimal invasion and good tolerance (15), some
aspects of hysteroscopy are still controversial
(16). Studies have reported the prevalence of
minor intrauterine pathologies on hysteroscopy in
patients with normal transvaginal ultrasonography
to be as high as 20-40% (17, 18). In this study,
we investigated women with normal endometrial
thickness on transvaginal ultrasonography and
performed hysteroscopic endometrial biopsies,
which showed different frequencies of endometrial
lesions between the PCOS and UI groups:
proliferative endometrium (54.3%), disordered
proliferative (17.1%), endometrial polyp (20%),
and secretory endometrium (8.6%) in the PCOS
group, while the most common histological
findings included secretory endometrium
(54.3%), proliferative endometrium (28.6%),
and endometrial polyp (17.1%) in the UI group,
with no disordered proliferative endometrium.
The high prevalence of endometrial disorders
in this study is an important finding considering
that previous studies reporting different rates
of endometrial hyperplasia in women with
PCOS have investigated patients with increased
endometrial thickness (19, 20), in whom significant
and prolonged increases in estrogen levels
can make the patients prone to endometrial
polyps, endometrial hyperplasia, and endometrial
cancer (19, 21, 22). In our study, exclusion of
patients with endometrial thickness revealed no
premalignant or malignant lesions in both the
PCOS and UI groups despite different endometrial
disorders. These results suggest the importance
of evaluating endometrial disorders in addition
to its association with endometrial thickness,
which has been previously demonstrated
(2).
Garuti and coworkers matched the
hysteroscopic findings with histological findings
in a large retrospective study on 1,500 women
undergoing diagnostic hysteroscopy and reported
endometritis, polyps, endometrial hyperplasia,
and endometrial malignancies in 21, 265,
185, and 102 patients, respectively (23). This
study suggested the highest sensitivity and
specificity of hysteroscopy in the diagnosis of
endometrial polyps and the worst sensitivity
and specificity in the diagnosis of endometrial
hyperplasia (23). Endometrial polyps are benign
proliferative lesions, which are incidentally
observed on transvaginal ultrasonography,
hysterosalpingography, and sonohysterogram
(13). Endometrial micropolyps, introduced as small
lesions (1-2 mm in length), can only be detected on
hysteroscopy (24, 25). Endometrial micropolyps are
associated with chronic endometritis (infiltration
of plasma cells in the endometrial stroma),
endometrial stromal edema, thickening, and
periglandular hyperemia (26). A retrospective study
reported the estimated prevalence of endometrial
micropolyps to be 11% on hysteroscopy using
conventional tissue staining and reported its
association with endometritis and infertility (24).
In the present study, micropolyps were identified
in 20% of patients in the PCOS group, although
no plasma cells were identified in the micropolyps
to diagnose endometritis. These results suggest
the importance of detecting micropolyps in
women with PCOS, although the identification of
plasma cells by conventional tissue staining (e.g.,
methylgreen-pyronin and hematoxylin-eosin) is not
easy even for experienced pathologists because
endometrial stromal plasma cells have similar
histological features as stromal fibroblasts and
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mononuclear leukocytes in the endometrium and
some morphological characteristics (superficial
edema and increased stromal cell density in
the secretory phase) may also interfere with
the identification of stromal plasma cells (27).
Thus, complementary diagnostic techniques
such as immunohistochemistry have been
suggested for the diagnosis of endometritis (28,
29). The importance of chronic endometritis
and micropolyps includes their association
with as well as their treatment effects on
infertility and endometrial hyperplasia/cancer
(30-32).
To the best of our knowledge, no studies
have reported the histological findings of women
with PCOS with normal hysteroscopic findings.
Generally, studies have reported a high correlation
between hysteroscopic and histological findings
for uterine cavity pathologies (33, 34), while
the superiority of histological findings over
hysteroscopy and hysteroscopic findings over
transvaginal ultrasonographic findings with
or without saline infusion for the detection
of endometrial lesions have been previously
suggested (35). In the present study, there
was no association between hysteroscopic and
histological findings, suggesting that normal
hysteroscopic findings do not indicate normal
endometrium and histopathology is required,
especially in women with PCOS even without
endometrial thickness. Although no premalignant
or malignant endometrial lesions were noted
in the present study, hysteroscopy without
biopsy could not identify endometrial polyps,
especially micropolyps detected on histology of
endometrial biopsies, possibly because of the
absence of endometrial thickening (>12 mm)
on transvaginal ultrasonography in both the
groups. In assessing endometrial polyps, small
nonsessile polyps were one of the limitations
in detecting endometrial abnormalities by
hysteroscopy.
5. Conclusion
The present study revealed that normal
hysteroscopic findings were associated with
abnormal endometrial biopsies in some infertile
women with PCOS without endometrial thickening,
suggesting that hysteroscopic evaluation alone
of infertile women without histological studies
might not be able to detect probable endometrial
pathologies such as micropolyps. Therefore,
performing hysteroscopic and histological
evaluations is recommended in all women
with PCOS even in cases with no endometrial
thickening or other abnormalities detected on
ultrasonography.
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